SCHEMBL10691670

SCHEMBL10691670

O=C(c1ccccc1)c1ccc2cnc(=O)oc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.48
HPGD P15428 4/20 0.48
RAB9A P51151 7/20 0.46
NPC1 O15118 3/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
MIF P14174 1/20 0.45
KDM4E B2RXH2 4/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
ATM Q13315 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
HTT P42858 1/20 0.44
TSHR P16473 1/20 0.42
MAPK1 P28482 1/20 0.42
POLB P06746 3/20 0.41
SCD O00767 1/20 0.41
SIGMAR1 Q99720 1/20 0.41
SRD5A2 P31213 1/20 0.41
USP2 O75604 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10691712 0.87 SRD5A2 (0.41) HPGDRAB9ANPC1MIFSMN1; SMN2
SCHEMBL8787024 0.80 PDE3B (0.45) ALDH1A1HPGDRAB9ANPC1MEN1
SCHEMBL28373618 0.78 CA12 (0.60) ALDH1A1HPGDRAB9ANPC1MEN1
SCHEMBL9437730 0.77 PTPN1 (0.47) ALDH1A1KDM4EPOLBMAPT
SCHEMBL10695779 0.74 ALDH1A1 (0.49) ALDH1A1HPGDRAB9ANPC1MEN1
SCHEMBL10926839 0.73 CA9 (0.56) ALDH1A1HPGDRAB9ANPC1MEN1
SCHEMBL6938 0.71 PDE3B (0.51) ALDH1A1HPGDRAB9ANPC1KDM4E
SCHEMBL30030322 0.71 PDE3B (0.51) ALDH1A1HPGDRAB9ANPC1KDM4E
SCHEMBL9718973 0.71 MEN1 (0.81) ALDH1A1HPGDRAB9ANPC1MEN1
Hydrochloric Acid SCHEMBL7394595 0.70 PDE3B (0.50) ALDH1A1HPGDRAB9ANPC1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4778792-A Use of 7-acyl benzoxazinones and their derivatives in treating atheromatous disorders LABORATORIES NEGMA (FR) 1988-10-18 US disclosed